Clover Health Investments, Corp.

NasdaqGS:CLOV Stok Raporu

Piyasa değeri: US$2.1b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Clover Health Investments Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Clover Health Investments'in gelirinin yıllık 2.4% oranında azalacağı tahmin edilirken, yıllık kazancının yıllık 19.8% oranında artması beklenmektedir. EPS'nin yılda 20.2% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde -16.8% olacağı tahmin edilmektedir.

Anahtar bilgiler

21.4%

Kazanç büyüme oranı

21.9%

EPS büyüme oranı

Healthcare kazanç büyümesi19.8%
Gelir büyüme oranı-1.7%
Gelecekteki özkaynak getirisi-19.9%
Analist kapsamı

Low

Son güncelleme08 Oct 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

There's Reason For Concern Over Clover Health Investments, Corp.'s (NASDAQ:CLOV) Massive 37% Price Jump

Oct 03
There's Reason For Concern Over Clover Health Investments, Corp.'s (NASDAQ:CLOV) Massive 37% Price Jump

Clover Health: Changing Business Model, Seeking Profitability

Oct 03

Clover Health: A Profitable Future Ahead Fueled By AI And Star Rating Success

Aug 15

Clover Health Investments, Corp. (NASDAQ:CLOV) Surges 32% Yet Its Low P/S Is No Reason For Excitement

Aug 14
Clover Health Investments, Corp. (NASDAQ:CLOV) Surges 32% Yet Its Low P/S Is No Reason For Excitement

Here's Why We're Watching Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

Aug 06
Here's Why We're Watching Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

Clover Health Investments, Corp.'s (NASDAQ:CLOV) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Jun 12
Clover Health Investments, Corp.'s (NASDAQ:CLOV) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Clover Health Investments, Corp.'s (NASDAQ:CLOV) 26% Dip In Price Shows Sentiment Is Matching Revenues

Apr 20
Clover Health Investments, Corp.'s (NASDAQ:CLOV) 26% Dip In Price Shows Sentiment Is Matching Revenues

Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year

Mar 16
Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year

Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?

Mar 06
Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?

Clover Health: Its Luck May Have Ran Out

Feb 26

Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

Nov 21
Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely

Jul 07
We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely

Chamath Palihapitiya-linked Clover Health Investments trading near all-time low

Oct 14

Chamath Palihapitiya cuts stake in Clover Health to under 5%

Oct 04

Rethinking My Clover Health Position

Sep 12

Clover Paid The Price Of Its Alleged Lies; Time To Move On

Aug 17

Clover Health Investments to name president Andrew Toy as CEO

Aug 08

Clover Health Is A Buy Ahead Of Earnings

Jul 29

Clover Health to expand Medicare Advantage plans to 13 additional counties, exit 2

Jul 15

Is Clover Health A Good Healthcare Sector Stock Pick?

Jun 30

Kazanç ve Gelir Büyüme Tahminleri

NasdaqGS:CLOV - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/20261,690-51N/AN/A2
12/31/20251,506-72N/AN/A3
12/31/20241,393-67N/AN/A3
6/30/20242,090-121-178-177N/A
3/31/20242,059-157-170-169N/A
12/31/20232,036-213-116-116N/A
9/30/20232,040-234-183-178N/A
6/30/20232,441-268-63-58N/A
3/31/20232,989-344-155-150N/A
12/31/20223,579-340-291-286N/A
9/30/20223,041-443-76-75N/A
6/30/20222,564-402-222-222N/A
3/31/20222,075-615-247-246N/A
12/31/20211,361-588-283-282N/A
9/30/20211,158-527-263-262N/A
6/30/2021922-487-252-252N/A
3/31/2021721-160-175-174N/A
12/31/2020690-136-119-118N/A
9/30/2020624-89-126-126N/A
6/30/2020572-145-116-116N/A
3/31/2020507-272-163-163N/A
12/31/2019455-364-160-160N/A
12/31/2018281-202-155-153N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: CLOV önümüzdeki 3 yıl boyunca kârsız kalmaya devam edeceği tahmin ediliyor.

Kazançlar ve Piyasa: CLOV önümüzdeki 3 yıl boyunca kârsız kalmaya devam edeceği tahmin ediliyor.

Yüksek Büyüme Kazançları: CLOV önümüzdeki 3 yıl boyunca kârsız kalmaya devam edeceği tahmin ediliyor.

Gelir ve Pazar: CLOV şirketinin gelirinin önümüzdeki 3 yıl içinde düşmesi bekleniyor (yılda -2.4% ).

Yüksek Büyüme Geliri: CLOV şirketinin gelirinin önümüzdeki 3 yıl içinde düşmesi öngörülüyor (yılda -2.4% ).

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: CLOV 3 yıl içinde kârsız olması bekleniyor.

Büyüyen şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y